Eli Lilly And Sanofi

Rediff.com » News » Eli Lilly And Sanofi

News for Eli Lilly And Sanofi

Business

1 insulin price cap for all brands

The National Pharmaceutical Pricing Authority has imposed a blanket ceiling on the prices of insulin, irrespective of the brand.While the move is set to bring down insulin prices, it has left the......

Global pharmas prefer emerging drug makers

Multinational drug manufacturers such as Pfizer and DSM are increasingly getting into contract manufacturing alliances with emerging bulk drug makers in the country, bypassing established players......

200 life-saving drugs to be cheaper

The National Pharmaceutical Pricing Authority (NPPA) has decided to revise the prices of over 200 life-saving medicines of wide-ranging therapeutic categories. While prices of a majority of these......

Imported insulin to cost more

The department of pharmaceuticals has asked the National Pharmaceutical Pricing Authority to review Eli Lilly’s imported insulin prices, kept in check in recent months.The move could result......

Consumers may have to pay more for insulin

Popular domestic brands of insulin analog Glargine (the chemical name) are in short supply for the past few months, forcing patients to switch to expensive imported alternatives, it is learnt.......

Rediff News

Eli Lilly And Sanofi

News for Eli Lilly And Sanofi

1 insulin price cap for all brands

Global pharmas prefer emerging drug makers

200 life-saving drugs to be cheaper

Imported insulin to cost more

Consumers may have to pay more for insulin

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS